(ENTA)—Correction re PRDS—The_daily_dose_of PBI-0451 in_the_ phase-2_trial_is 1400mg, not 700mg as stated in the post I’m replying to. The 1400mg daily dose consists of four 350mg tablets (2 in the morning, 2 at night) that must be taken with food.
By comparison, ENTA’s phase-2 daily dose of EDP-235 is one 200mg or 400mg tablet (taken with or without food), which is 14-28% of PRDS’s daily dose (#msg-169530604).
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.